Researchers at Nicklaus Children’s Hospital in Miami, Florida have performed the first procedure in a pediatric and young adult brain tumor study. The trial aims to demonstrate feasibility and safety of using focused ultrasound to ablate a variety of benign tumors that can cause epilepsy and other complications in ten patients, ages 8 to 22.
The Foundation is pleased to be the recipient of acac Fitness & Wellness Centers’ most successful “Work Out and Give Back” campaign to date. Throughout the month of March, people were able to purchase a 30-day membership for $30 at any of the 12 acac locations. In all, over 3,000 people participated in the event, raising more than $90,000 for the Foundation.
Phil Wendel has been passionate about improving lives through fitness for decades. Now, the founder and CEO of Charlottesville, Va.-based acac Fitness & Wellness Centers, supports the Foundation’s efforts to improve lives using focused ultrasound. “To know that an alternative therapy exists that will significantly lower costs and make patient experience exponentially better, it was common sense for me to get involved.”
In the April issue of DOTmed Healthcare Business News, Foundation Chief Scientific Officer, Jessica Foley, PhD, writes about how the biomedical community is shifting toward a culture of collaboration and what that means for focused ultrasound and many other areas of medical research. She explains how the Foundation is an example of this new trend, paving the way for indications like essential tremor to reach regulatory approval.
The Foundation has established an annual $75,000 cash award that will be given to an investigator who demonstrates outstanding potential to contribute to advancing cancer treatment using focused ultrasound. The Andrew J. Lockhart Memorial Prize was established by Andrew’s family, with the hope that research can contribute to new therapies for solid cancers.
April is Parkinson's Awareness Month, and we're celebrating by sharing Steve's story of focused ultrasound treatment.
Diagnosed at age 25, Steve’s Parkinson’s symptoms were affecting his career and keeping him from the outdoor activities he loved. Then, social media – and a little digging – led him to focused ultrasound. Now he and his family hit the road in support of Team Fox.
On April 1, Dr. Mehmet Oz, Emmy Award-winning host of The Dr. Oz Show, hosted a live health and safety festival in South Florida that featured an educational seminar on focused ultrasound technology. Three physicians spoke on why they are passionate about using the technology and how it is changing patients’ lives. An estimated 7,000 people attended the day’s events.
A new study published in the Journal of Clinical Investigation Insight suggests that combining focused ultrasound ablation with immunotherapy in the right order can produce a systemic attack on epithelial cancer in a mouse model.
Katherine Ferrara, PhD, and her team at the University of California Davis achieved these results in a study that was partially funded by the Foundation.
Researchers at the Queensland Brain Institute recently published new work describing their use of focused ultrasound and immunotherapy in treating a mouse model of Alzheimer’s disease. Dr. Jürgen Götz and his team discovered that administering a novel tau-specific antibody fragment (“RN2N”) to the brain – after focused ultrasound opened the blood-brain barrier – markedly increased its uptake by neurons and enhanced efficacy. The higher levels of RN2N in the brain reduced anxiety-like behavior in the mice and decreased tau phosphorylation at distinct sites.
Two of the articles featured this month further explore using focused ultrasound and microbubbles to open the blood-brain barrier. One investigates how this mechanism affects the microvasculature of the brain, and the other shows its promise in delivering chemotherapy to invasive brain tumors. Finally, a third paper by a group in Hong Kong proposes a new protocol for large, treatment-resistant thyroid nodules.
France-based Theraclion has published two-year results from a European breast fibroadenoma study using their Echopulse system. The paper assessed 20 patients with 26 breast fibroadenomas and monitored them up to 24 months. Most patients received a single treatment, but some needed a second treatment six to nine months after the initial session. Fibroadenoma volume, patient satisfaction, symptom relief, and safety and tolerability were assessed with positive and sustained results. READ MORE >
SonaCare Medical has launched an international patient registry entitled High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT). The globally accessible, web-based platform for storing data on patients treated with the Sonablate system will collect longitudinal clinical information for assessing procedures, outcomes, and effectiveness. Participating physicians will have access to collaborate with international colleagues. HEAT has enrolled more than 1,500 international patients, and US enrollment began this month. READ MORE >
In their April “Device Talk” blog, Medical Device and Diagnostic Industry (MD+DI) describes how the medical device industry is uniquely affected by the 21st Century Cures Act. From a new breakthrough device pathway and changes in review procedures at the FDA to single vs. multi-institutional IRB oversight, these eight bullet points might affect your company or your academic research. READ MORE >